Apolipoprotein E polymorphism is not a predictor for repeated coronary artery bypass surgery

Scandinavian Cardiovascular Journal

Volumn 39, Issue 4, 2005, Pages 220-224

  Kuukasjärvi, Pekka ^a   Tarkka, Matti ^a   Mennander, Ari ^a   Ilveskoski, Erkki ^a,b   Koivisto, Anna Maija ^a,c   Laippala, Pekka ^a,c   Mikkelsson, Jussi ^a,b   Karhunen, Pekka J ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Apolipoprotein E; Coronary artery bypass; Family history; Hypercholesterolemia; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; DNA;

ADULT; AGE; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DNA DETERMINATION; FAMILY HISTORY; FEMALE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAFT OCCLUSION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REOPERATION; RISK FACTOR;

AGED; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; REOPERATION; TREATMENT OUTCOME;

EID: 25444471553     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430510009159     Document Type: Article

References (23)

1. Weintraub WS, Jones EL, Craver JM, Grosswald R, Guyton RA. In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery. Circulation. 1995;92:II50.
2. Shuhaiber JH, Evans AN, Massad MG, Geha AS. Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery. Eur J Cardiothorac Surg. 2002;22:387-96.
3. Buxton B, Goldblatt J, Komeda M. Reoperation. In: Buxton B, Frazier OH, Westaby S, editors. Ischemic heart disease surgical management. London: Mosby; 1999. p. 241-50.
4. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA. 1990;264:3018-24.
5. Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol. 1996;16:1250-5.
6. Ilveskoski E, Perola M, Lehtimaki T, Laippala P, Savolainen V, Pajarinen J, et al. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: An autopsy study. Circulation. 1999; 100:608-13.
7. van Bockxmeer FM, Mamotte CD. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet. 1992;340:879-80.
8. Newman MF, Laskowitz DT, White WD, Kirchner JL, Grocott HP, Stafford-Smith M, et al. Apolipoprotein E polymorphisms and age at first coronary artery bypass graft. Anesth Analg. 2001;92:824-9.
9. Chew ST, Newman MF, White WD, Conlon PJ, Saunders AM, Strittmatter WJ, et al. Preliminary report on the association of apolipoprotein E polymorphisms, with post-operative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology. 2000;93:325-31.
10. Steed L, Kong R, Stygall J, Acharya J, Bolla M, Harrison MJ, et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Ann Thorac Surg. 2001;71:823-6.
11. Tardiff BE, Newman MF, Saunders AM, Strittmatter WJ, Blumenthal JA, White WD, et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg. 1997;64:715-20.
12. Ilveskoski E, Lehtimaki T, Erkinjuntti T, Koivula T, Karhunen PJ. Rapid apolipoprotein E genotyping from mailed buccal swabs. J Neurosci Methods. 1998;79:5-8.
13. Grundy SM, Pasternak R, Greenland P, Smith S, Jr. Fuster V. AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 1999;34:1348-59.
14. Lehtinen S, Lehtimaki T, Sisto T, Salenius JP, Nikkila M, Jokela H, et al. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis. 1995;114:83-91.
15. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol. 1995;15:1280-6.
16. van Bockxmeer FM, Mamotte CD, Gibbons FA, Burke V, Taylor RR. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation. 1995;92:2066-71.
17. Samani NJ, Martin DS, Brack M, Cullen J, Wallis R, Lodwick D, et al. Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty. Atherosclerosis. 1996;125:209-16.
18. Ortlepp JR, Janssens U, Bleckmann F, Lauscher J, Merkelbach-Bruse S, Hanrath P, et al. A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts. Coron Artery Dis. 2001;12:493-7.
19. Koch W, Kastrati A, Mehilli J, Bottiger C, von Beckerath N, Schomig A. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation. 2000;102:197-202.
20. Zotz RB, Klein M, Dauben HP, Moser C, Gams E, Scharf RE. Prospective analysis after coronary-artery bypass grafting: Platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death. Thromb Haemost. 2000;83:404-7.
21. Jarvik GP, Goode EL, Austin MA, Auwerx J, Deeb S, Schellenberg GD, et al. Evidence that the apolipoprotein E-genotype effects on lipid levels can change with age in males: A longitudinal analysis. Am J Hum Genet. 1997;61:171-81.
22. Cambien F. Insight into the genetic epidemiology of coronary heart disease. Ann Med. 1996;28:465-70.
23. Funke H, Assmann G. Strategies for the assessment of genetic coronary artery disease risk. Curr Opin Lipidol. 1999;10: 285-91.